Invention Grant
- Patent Title: Contrast agents for magnetic resonance imaging
-
Application No.: US16946056Application Date: 2020-06-04
-
Publication No.: US11235074B2Publication Date: 2022-02-01
- Inventor: Christopher David Lascola
- Applicant: Duke University
- Applicant Address: US NC Durham
- Assignee: Duke University
- Current Assignee: Duke University
- Current Assignee Address: US NC Durham
- Agency: Myers Bigel, P.A.
- Main IPC: A61K49/06
- IPC: A61K49/06 ; A61K49/10 ; A61B5/00 ; A61K9/00 ; A61B5/055 ; A61K9/08 ; A61K47/02 ; A61K47/26

Abstract:
Ascorbate or a pharmaceutically acceptable salt thereof is described for use in carrying out a method, or for the preparation of a medicament for carrying out a method, of enhancing a magnetic resonance imaging (MRI) image of a body or body region such as an organ or organ region in a subject. The method is carried out by parenterally administering ascorbate or a pharmaceutically acceptable salt thereof to the subject in an MRI image-enhancing amount; and then generating, by MRI of the subject, an image of the body or body region. The ascorbate or pharmaceutically acceptable salt thereof enhances the MRI image.
Public/Granted literature
- US20200297873A1 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING Public/Granted day:2020-09-24
Information query